All Stories

  1. Copper regulates the host innate immune response against bacterial infection via activation of ALPK1 kinase
  2. Development of Pan-Anti-SARS-CoV-2 Agents through Allosteric Inhibition of nsp14/nsp10 Complex
  3. SaeR as a novel target for antivirulence therapy against Staphylococcus aureus
  4. Metallo-sideromycin as a dual functional complex for combating antimicrobial resistance
  5. Metalloproteomics
  6. Mitochondrial ATP synthase as a direct molecular target of chromium(III) to ameliorate hyperglycaemia stress
  7. Rapid synthesis of bismuth-organic frameworks as selective antimicrobial materials against microbial biofilms
  8. Gold drugs as colistin adjuvants in the fight against MCR-1 producing bacteria
  9. A dual covalent binder for labelling and inhibiting serine and metallo-carbapenemases
  10. Dual-action gallium-flavonoid compounds for combating Pseudomonas aeruginosa infection
  11. Metallomics and metalloproteomics
  12. Metal-coding assisted serological multi-omics profiling deciphers the role of selenium in COVID-19 immunity
  13. Metal Complexes as Resistance Breakers or Metalloantibiotics for Combating Antimicrobial Resistance
  14. Computed Tomography of Cartilage: An Exploration of Novel Cationic Bismuth Contrast Agent
  15. Binding of ruthenium and osmium at non‑iron sites of transferrin accounts for their iron-independent cellular uptake
  16. An ensemble 3D deep-learning model to predict protein metal-binding site
  17. Metalloproteomics for Biomedical Research: Methodology and Applications
  18. Re-sensitization of mcr carrying multidrug resistant bacteria to colistin by silver
  19. Regulation of DNA-binding activity of the Staphylococcus aureus catabolite control protein A by copper (II)-mediated oxidation
  20. A hydroxide lock for metallo-β-lactamases
  21. Orally administered bismuth drug together with N-acetyl cysteine as a broad-spectrum anti-coronavirus cocktail therapy
  22. Multiplex metal-detection based assay (MMDA) for COVID-19 diagnosis and identification of disease severity biomarkers
  23. Metal-based strategies for the fight against COVID-19
  24. Multiplex Single‐Cell Analysis of Cancer Cells Enables Unbiased Uncovering Subsets Associated with Cancer Relapse: Heterogeneity of Multidrug Resistance in Precursor B‐ALL
  25. Eradication of Porphyromonas gingivalis Persisters Through Colloidal Bismuth Subcitrate Synergistically Combined With Metronidazole
  26. Author Correction: Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance
  27. Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance
  28. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2
  29. Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles
  30. A. Sigel, E. Freisinger & R. K. O. Sigel (Eds.), M. E. Sosa Torres & P. M. H. Kroneck (volume Eds.): Transition Metals and Sulfur – A Strong Relationship for Life
  31. Resensitizing carbapenem- and colistin-resistant bacteria to antibiotics using auranofin
  32. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
  33. Metalloproteomics in conjunction with other omics for uncovering the mechanism of action of metallodrugs: Mechanism-driven new therapy development
  34. Bismuth—The Magic Element
  35. Atomic differentiation of silver binding preference in protein targets:Escherichia colimalate dehydrogenase as a paradigm
  36. Bismuth drugs as antimicrobial agents
  37. Predicting disease-associated mutation of metal-binding sites in proteins using a deep learning approach
  38. Zinc excess increases cellular demand for iron and decreases tolerance to copper in Escherichia coli
  39. Recognition of Proteins by Metal Chelation-Based Fluorescent Probes in Cells
  40. Metalloproteomics for Unveiling the Mechanism of Action of Metallodrugs
  41. Deciphering molecular mechanism of silver by integrated omic approaches enables enhancing its antimicrobial efficacy in E. coli
  42. Bismuth drugs tackle Porphyromonas gingivalis and attune cytokine response in human cells
  43. The unique trimeric assembly of the virulence factor HtrA from Helicobacter pylori occurs via N-terminal domain swapping
  44. A Novel Synthetic Compound, Bismuth Zinc Citrate, Could Potentially Reduce Cisplatin-Induced Toxicity Without Compromising the Anticancer Effect Through Enhanced Expression of Antioxidant Protein
  45. Green Fluorescent Probe for Imaging His6-Tagged Proteins Inside Living Cells
  46. MetaMarker: a pipeline for de novo discovery of novel metagenomic biomarkers
  47. Antimicrobial silver targets glyceraldehyde-3-phosphate dehydrogenase in glycolysis of E. coli
  48. Bismuth: Environmental Pollution and Health Effects
  49. Combination of gallium(iii) with acetate for combating antibiotic resistant Pseudomonas aeruginosa
  50. S-Dimethylarsino-glutathione (darinaparsin®) targets histone H3.3, leading to TRAIL-induced apoptosis in leukemia cells
  51. Systems Approaches for Unveiling the Mechanism of Action of Bismuth Drugs: New Medicinal Applications beyond Helicobacter Pylori Infection
  52. Cell Cycle-Dependent Uptake and Cytotoxicity of Arsenic-Based Drugs in Single Leukemia Cells
  53. The role of citrate, lactate and transferrin in determining titanium release from surgical devices into human serum
  54. Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors
  55. Metallochaperone UreG serves as a new target for design of urease inhibitor: A novel strategy for development of antimicrobials
  56. Multi-omics and temporal dynamics profiling reveal disruption of central metabolism inHelicobacter pylorion bismuth treatment
  57. Tracking iron-associated proteomes in pathogens by a fluorescence approach
  58. Functional disruption of peroxiredoxin by bismuth antiulcer drugs attenuates Helicobacter pylori survival
  59. A Ni-NTA-based red fluorescence probe for protein labelling in live cells
  60. Cytotoxicity of arsenic trioxide in single leukemia cells by time-resolved ICP-MS together with lanthanide tags
  61. Identification of catabolite control protein A fromStaphylococcus aureusas a target of silver ions
  62. Integration of fluorescence imaging with proteomics enables visualization and identification of metallo-proteomes in living cells
  63. Integrative approach for the analysis of the proteome-wide response to bismuth drugs in Helicobacter pylori
  64. Exploration into the nickel ‘microcosmos’ in prokaryotes
  65. UreE-UreG Complex Facilitates Nickel Transfer and Preactivates GTPase of UreG in Helicobacter pylori
  66. Glutathione and multidrug resistance protein transporter mediate a self-propelled disposal of bismuth in human cells
  67. Rapid labeling of intracellular His-tagged proteins in living cells
  68. Loss of APD1 in Yeast Confers Hydroxyurea Sensitivity Suppressed by Yap1p Transcription Factor
  69. Metallomic and metalloproteomic strategies in elucidating the molecular mechanisms of metallodrugs
  70. “Anion clamp” allows flexible protein to impose coordination geometry on metal ions
  71. On-line coupling of continuous-flow gel electrophoresis with inductively coupled plasma-mass spectrometry to quantitatively evaluate intracellular metal binding properties of metallochaperones HpHypA and HpHspA in E. coli cells
  72. Bio-coordination of bismuth in Helicobacter pylori revealed by immobilized metal affinity chromatography
  73. Selective interaction of Hpn-like protein with nickel, zinc and bismuth in vitro and in cells by FRET
  74. Antimony and Bismuth
  75. Structure of RPA32 bound to the N‐terminus of SMARCAL1 redefines the binding interface between RPA32 and its interacting proteins
  76. Urease inactivation by an unusual GroES chaperonin
  77. Functional disruption of HypB, a GTPase of Helicobacter pylori, by bismuth
  78. In-cell NMR: an emerging approach for monitoring metal-related events in living cells
  79. Size-tunable fabrication of multifunctional Bi2O3 porous nanospheres for photocatalysis, bacteria inactivation and template-synthesis
  80. Nickel translocation between metallochaperones HypA and UreE in Helicobacter pylori
  81. BiOX (X=Cl, Br, I) nanostructures: Mannitol-mediated microwave synthesis, visible light photocatalytic performance, and Cr(VI) removal capacity
  82. Identification of Metal‐Associated Proteins in Cells by Using Continuous‐Flow Gel Electrophoresis and Inductively Coupled Plasma Mass Spectrometry
  83. ChemInform Abstract: Template‐Free Fabrication of Bi2O3 and (BiO)2CO3 Nanotubes and Their Application in Water Treatment.
  84. Tunable BiOCl hierarchical nanostructures for high-efficient photocatalysis under visible light irradiation
  85. Kinetics and thermodynamics of metal binding to the N-terminus of a human copper transporter, hCTR1
  86. Binding of oxo-Cu2 clusters to ferric ion-binding protein A from Neisseria gonorrhoeae: a structural insight
  87. Histidine-rich proteins in prokaryotes: metal homeostasis and environmental habitat-related occurrence
  88. Interaction of SlyD with HypB of Helicobacter pylori facilitates nickel trafficking
  89. Structure-oriented bioinformatic approach exploring histidine-rich clusters in proteins
  90. Iron and bismuth bound human serum transferrin reveals a partially-opened conformation in the N-lobe
  91. Template‐Free Fabrication of Bi2O3 and (BiO)2CO3 Nanotubes and Their Application in Water Treatment
  92. Metallomics in environmental and health related research: Current status and perspectives
  93. Facile Microwave Synthesis of 3D Flowerlike BiOBr Nanostructures and Their Excellent CrVI Removal Capacity
  94. Recent advances in bioinorganic chemistry of bismuth
  95. Folic acid conjugated mPEG-PEI600 as an efficient non-viral vector for targeted nucleic acid delivery
  96. Covalently linking the Escherichia coli global anaerobic regulator FNR in tandem allows it to function as an oxygen stable dimer
  97. Metallo-GTPase HypB from Helicobacter pylori and Its Interaction with Nickel Chaperone Protein HypA
  98. Large-scale synthesis of bismuth hollow nanospheres for highly efficient Cr(vi) removal
  99. Activation of carboplatin and nedaplatin by the N-terminus of human copper transporter 1 (hCTR1)
  100. Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1)
  101. Probing of bismuth antiulcer drug targets in H. pylori by laser ablation-inductively coupled plasma mass spectrometry
  102. Multifaceted SlyD from Helicobacter pylori: implication in [NiFe] hydrogenase maturation
  103. Microwave synthesis of BiPO4 nanostructures and their morphology-dependent photocatalytic performances
  104. Assembly of Preactivation Complex for Urease Maturation inHelicobacter pylori
  105. Histidine-rich protein Hpn from Helicobacter pylori forms amyloid-like fibrils in vitro and inhibits the proliferation of gastric epithelial AGS cells
  106. Tracking Bismuth Antiulcer Drug Uptake in Single Helicobacter pylori Cells
  107. Metal‐Binding Properties of an Hpn‐Like Histidine‐Rich Protein
  108. The Effect of the Extracellular Domain of Human Copper Transporter (hCTR1) on Cisplatin Activation
  109. The Effect of the Extracellular Domain of Human Copper Transporter (hCTR1) on Cisplatin Activation
  110. NMR Studies of Metalloproteins
  111. Biological Chemistry of Arsenic, Antimony and Bismuth
  112. Biological Chemistry of Antimony and Bismuth
  113. Metalloproteomics of Arsenic, Antimony and Bismuth Based Drugs
  114. Polymeric architectures of bismuth citrate based on dimeric building blocks
  115. Online coupling of reverse-phase and hydrophilic interaction liquid chromatography for protein and glycoprotein characterization
  116. Iron-containing lipoprotein SiaA in SiaABC, the primary heme transporter of Streptococcus pyogenes
  117. Nuclear-based Metallomics in Metal-based Drugs
  118. Bismuth subcarbonate nanoparticles fabricated by water-in-oil microemulsion-assisted hydrothermal process exhibit anti-Helicobacter pylori properties
  119. A new capillary electrophoresis buffer for determining organic and inorganic anions in electroplating bath with surfactant additives
  120. A zinc-binding site by negative selection induces metallodrug susceptibility in an essential chaperonin
  121. A biomimetic zinc activated ion channel
  122. Metallomics: An integrated science for metals in biology and medicine
  123. Metallomics: An integrated biometal science
  124. Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1
  125. Effect of cyclodextrin dimers with bipyridyl and biphenyl linking groups on carboxyl ester hydrolysis catalyzed by zinc complex
  126. Structure of a Nickel Chaperone, HypA, from Helicobacter pylori Reveals Two Distinct Metal Binding Sites
  127. Iron depletion decreases proliferation and induces apoptosis in a human colonic adenocarcinoma cell line, Caco2
  128. The structural and biological significance of the EAAEAE insert in the α-domain of human neuronal growth inhibitory factor
  129. Crystal Structure and Metal Binding Properties of the Lipoprotein MtsA, Responsible for Iron Transport in Streptococcus pyogenes
  130. Phosphodiester hydrolysis and specific DNA binding and cleavage promoted by guanidinium-functionalized zinc complexes
  131. Important roles of the conserved linker-KKS in human neuronal growth inhibitory factor
  132. Identification and characterization of metallodrug binding proteins by (metallo)proteomics
  133. Editorial and Advisory Board profiles
  134. Identification of Proteins Related to Nickel Homeostasis in Helicobater pylori by Immobilized Metal Affinity Chromatography and Two-Dimensional Gel Electrophoresis
  135. Study on structure–property–reactivity–function relationship of human neuronal growth inhibitory factor (hGIF)
  136. Binding of Ni2+ to a histidine- and glutamine-rich protein, Hpn-like
  137. Structure, topology and assembly of a 32-mer peptide corresponding to the loop 3 and transmembrane domain 4 of divalent metal transporter (DMT1) in membrane-mimetic environments
  138. A Histidine-rich and Cysteine-rich Metal-binding Domain at the C Terminus of Heat Shock Protein A from Helicobacter pylori
  139. Lipoprotein MtsA of MtsABC in Streptococcus pyogenes primarily binds ferrous ion with bicarbonate as a synergistic anion
  140. Double-strand DNA cleavage by copper complexes of 2,2′-dipyridyl with guanidinium/ammonium pendants
  141. The effect of nitric oxide on metal release from metallothionein-3: gradual unfolding of the protein
  142. Biocoordination chemistry of bismuth: Recent advances
  143. Effect of α-domain substitution on the structure, property and function of human neuronal growth inhibitory factor
  144. Bismuth Complexes Inhibit the SARS Coronavirus
  145. Bismuth Complexes Inhibit the SARS Coronavirus
  146. Bioinorganic Chemistry of Bismuth and Antimony: Target Sites of Metallodrugs
  147. A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori
  148. Solution structures, dynamics, and lipid‐binding of the sterile α‐motif domain of the deleted in liver cancer 2
  149. Structural prediction of the β-domain of metallothionein-3 by molecular dynamics simulation
  150. Metallodrugs
  151. An Effective Metallohydrolase Model with a Supramolecular Environment: Structures, Properties, and Activities
  152. Bioinorganic Chemistry of Bismuth and Antimony:  Target Sites of Metallodrugs
  153. Silver nanoparticles: partial oxidation and antibacterial activities
  154. Synthesis, Structure, and Activity of Supramolecular Mimics for the Active Site and Arg141 Residue of Copper, Zinc−Superoxide Dismutase
  155. Encapsulation of platinum anticancer drugs by apoferritin
  156. Inhibition of SARS coronavirus helicase by bismuth complexes
  157. Cleavage of double-strand DNA by zinc complexes of dicationic 2,2′-dipyridyl derivatives
  158. Flavonoid Dimers as Bivalent Modulators for Pentamidine and Sodium Stiboglucanate Resistance in Leishmania
  159. Inhibition of urease by bismuth(III): Implications for the mechanism of action of bismuth drugs
  160. Mutation at Glu23 eliminates the neuron growth inhibitory activity of human metallothionein-3
  161. Thermodynamic and Kinetic Aspects of Metal Binding to the Histidine-rich Protein, Hpn
  162. The role of Thr5 in human neuron growth inhibitory factor
  163. Proteomic Analysis of the Mode of Antibacterial Action of Silver Nanoparticles
  164. Solution structure and dynamics of human metallothionein‐3 (MT‐3)
  165. HFIP‐induced structures and assemblies of the peptides from the transmembrane domain 4 of membrane protein Nramp1
  166. Fabrication of bismuth subcarbonate nanotube arrays from bismuth citrate
  167. Expression and characterization of a histidine-rich protein, Hpn: potential for Ni 2+ storage in Helicobacter pylori
  168. Complexation of antimony (SbV) with guanosine 5′-monophosphate and guanosine 5′-diphospho-d-mannose: Formation of both mono- and bis-adducts
  169. An Insight of S-Nitrosylation of Human GIF
  170. The Stepwise Process of Chromium-Induced DNA Breakage:  Characterization by Electrochemistry, Atomic Force Microscopy, and DNA Electrophoresis
  171. Transferrin-Mediated Gold Nanoparticle Cellular Uptake
  172. 51 Sb Antimony in Medicine
  173. NMR structures and orientation of the fourth transmembrane domain of the rat divalent metal transporter (DMT1) with G185D mutation in SDS micelles
  174. Structure, Assembly, and Topology of the G185R Mutant of the Fourth Transmembrane Domain of Divalent Metal Transporter
  175. Controlled synthesis of high crystalline bismuth sulfide nanorods: using bismuth citrate as a precursor
  176. In Vitro Inhibition of Human Immunodeficiency Virus Type‐1 (HIV‐1) Reverse Transcriptase by Gold(III) Porphyrins
  177. Dynamic and Kinetic Aspects of Metallodrugs by NMR
  178. The low pKa value of iron‐binding ligand Tyr188 and its implication in iron release and anion binding of human transferrin
  179. Inhibition of alcohol dehydrogenase by bismuth☆
  180. Structure and topology of the transmembrane domain 4 of the divalent metal transporter in membrane‐mimetic environments
  181. Bismuth in Medicine
  182. DNA hydrolysis promoted by di- and multi-nuclear metal complexes
  183. The effect of the EAAEAE insert on the property of human metallothionein-3
  184. Structure of Colloidal Bismuth Subcitrate (CBS) in Dilute HCl:  Unique Assembly of Bismuth Citrate Dinuclear Units ([Bi(cit)2Bi]2-)
  185. Recognition of antimony and bismuth by peptides and proteins: insight into the mechanism of action
  186. Three dimensional structures and topology of the transmembrane domain 4 of divalent metal transporter (DMT1) in membrane-mimetic environments
  187. Reduction of pentavalent antimony by trypanothione and formation of a binary and ternary complex of antimony(III) and trypanothione
  188. Membrane-inserted conformation of transmembrane domain 4 of divalent-metal transporter
  189. Binding of bismuth to serum proteins: implication for targets of Bi(III) in blood plasma
  190. Gold(iii) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cellsElectronic supplementary information (ESI) available: Further experimental and crystallographic details...
  191. An oscillating C22? unit inside a copper rectangleElectronic supplementary information (ESI) available: NMR spectra and computational details. See http://www.rsc.org/suppdata/cc/b3/b301842c/
  192. Helicases as antiviral drug targets
  193. Rapid reduction of pentavalent antimony by trypanothione: potential relevance to antimonial activationElectronic supplementary information (ESI) available: experimental details. See http://www.rsc.org/suppdata/cc/b2/b210240d/
  194. Complexation of ytterbium to human transferrin and its uptake by K562 cells
  195. Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
  196. Stereo- and Enantioselective Alkene Epoxidations: A Comparative Study of D4- and D2-Symmetric Homochiral trans-Dioxoruthenium(VI) Porphyrins
  197. The role of the transferrin–transferrin-receptor system in drug delivery and targeting
  198. Interactions of Bismuth with Human Lactoferrin and Recognition of the BiIII−Lactoferrin Complex by Intestinal Cells
  199. Competitive Binding of Bismuth to Transferrin and Albumin in Aqueous Solution and in Blood Plasma
  200. Intracellular Sb-trypanothione
  201. Complexation of Antimony(III) by Trypanothione
  202. Interaction of antimony tartrate with the tripeptide glutathione
  203. TiIV Uptake and Release by Human Serum Transferrin and Recognition of TiIV-Transferrin by Cancer Cells:  Understanding the Mechanism of Action of the Anticancer Drug Titanocene Dichloride
  204. Stereoselective Formation of Seven-Coordinate Titanium(IV) Monomer and Dimer Complexes of Ethylenebis(o-hydroxyphenyl)glycine
  205. ChemInform Abstract: Transferrin as a Metal Ion Mediator
  206. Interactions of Bismuth Complexes with Metallothionein(II)
  207. Transferrin as a Metal Ion Mediator
  208. Coordination chemistry of metals in medicine: target sites for bismuth
  209. Bismuth Antiulcer Complexes
  210. N-lobe versus C-lobe complexation of bismuth by human transferrin
  211. Coordination of Zn2+ (and Cd2+) by Prokaryotic Metallothionein
  212. The First Specific TiIV-Protein Complex: Potential Relevance to Anticancer Activity of Titanocenes
  213. [1H,13C] NMR determination of the order of lobe loading of human transferrin with iron: comparison with other metal ions
  214. New approach to the solution chemistry of bismuth citrate antiulcer complexes
  215. The Biological and Medicinal Chemistry of Bismuth
  216. Determination of Bismuth in Serum Urine by Direct Injection Nebulization Inductively Coupled Plasma Mass Spectrometry
  217. Rationalisation of metal binding to transferrin: Prediction of metal-protein stability constants
  218. Rationalization of the Strength of Metal Binding to Human Serum Transferrin
  219. Molecular assemblies of diazafluorenone Schiff-base amphiphiles. III.13C NMR investigations of reversed micelles in deuteriochloroform
  220. Bismuth(III) Complexes of the Tripeptide Glutathione (γ‐L‐Glu–L‐Cys–Gly)
  221. Solid-state carbon-13 nuclear magnetic resonance investigations of bismuth citrate complexes and crystal structure of Na2[Bi2(cit)2]·7H2O
  222. 1H NMR Studies of the Imidazole Complex of Cytochrome c: Resonance Assignment and Structural Characterization of the Heme Cavity
  223. Ranitidine bismuth(III) citrate
  224. NMR Investigation of the Aggregation Behavior of Diazafluorenone Schiff Base Amphiphile in CDCL3Solution
  225. Assignments of Nonexchangeable Proton Resonances and the Solution Structures of d–TGGGT
  226. Syntheses and Characterization of Coenzyme B12 Analogues Containing 2′-Deoxynucleosede
  227. Two Dimensional1HNMR Studies on 2′5′-Dideoxyadenosylcobalamin